Artherstrasse 153, 6317 Oberwil bei Zug, Switzerland
Give us a call: 041 725 40 30
Artherstrasse 153, 6317 Oberwil bei Zug, Switzerland
Give us a call: 041 725 40 30
Discover the effective foam sclerotherapy for spider veins. Learn more about our gentle method for treating fine varicose veins.
Small varicose veins (so-called spider veins) can be removed by sclerotherapy. The treatment method of sclerotherapy, in which the varicose veins are glued together by cauterization, is suitable for removing superficial varicose veins (so-called spider veins). During sclerotherapy, a small amount of the vessel wall irritant (aethoxysclerol) is injected into the affected vessel using a very fine needle (I use the invisible needle). This causes the vessel walls to stick together, which leads to resorption (dissolution) of the affected veins.
The treatment is not painful
The foam sclerotherapy procedure is not painful. At most, a slight burning sensation may occur at the injection site. Hardening and hematomas (bruises) occasionally occur after the treatment. These are completely harmless and disappear within a few weeks. Intolerances and allergic reactions of the skin in the area of the sclerotherapy site are the exception. Skin necrosis is extremely rare.
Foam sclerotherapy, the new, modern form of sclerotherapy
The modern form of sclerotherapy is foam sclerotherapy (foam sclerotherapy). A proven and established liquid sclerosing agent is mixed with a precisely defined amount of sterile air and emulsified, i.e. foamed up. The foam produced in this way is injected into the spider veins through an ultra-fine needle. The foam displaces the blood and has a direct adhesive effect on the vessel wall. Unlike conventional treatment with liquid sclerosing agents, the sclerosing foam is not diluted by the blood and thus not washed into the deep venous system.
Therefore, comparatively lower concentrations and amounts of sclerosing foam have a stronger effect than the liquid sclerosing agent and also have fewer side effects, which increases the safety and success of the treatment. This means that hardly any side effects are to be expected with foam sclerosing and the treatment achieves its goal much more quickly. The limiting factor of the maximum number of treatments that can be carried out in one session is the best tolerated amount of sclerosing agent required. For this reason, a consultation for assessment and advice before treatment is essential when planning the therapy.
Robert Patrick van der Kruijssen